TY - JOUR
T1 - Autophagy
T2 - An adaptive metabolic response to stress shaping the antitumor immunity
AU - Viry, Elodie
AU - Paggetti, Jerome
AU - Baginska, Joanna
AU - Mgrditchian, Takouhie
AU - Berchem, Guy
AU - Moussay, Etienne
AU - Janji, Bassam
N1 - Funding Information:
This work was supported by grants from CRP-Santé ( REC-LHCE-2013-1105 ), Kriibskrank Kanner Foundation ( FON-LHCE-2013-1005 ), Caloust Gulbenkian Foundation , Télévie ( 7.4628.12F , 7.4606.13 and 7.4504.11F ) and “ Fonds National de la Recherche ” (FNR) Luxembourg ( C12/BM/3962058 and AFR 7842786 ).
Publisher Copyright:
© 2014 Elsevier Inc.
PY - 2014/11/1
Y1 - 2014/11/1
N2 - Several environmental-associated stress conditions, including hypoxia, starvation, oxidative stress, fast growth and cell death suppression, modulate both cellular metabolism and autophagy to enable cancer cells to rapidly adapt to environmental stressors, maintain proliferation and evade therapies. It is now widely accepted that autophagy is essential to support cancer cell growth and metabolism and that metabolic reprogramming in cancer can also favor autophagy induction. Therefore, this complex interplay between autophagy and tumor cell metabolism will provide unique opportunities to identify new therapeutic targets. As the regulation of the autophagic activity is related to metabolism, it is important to elucidate the exact molecular mechanism which drives it and the functional consequence of its activation in the context of cancer therapy. In this review, we will summarize the role of autophagy in shaping the cellular response to an abnormal tumor microenvironment and discuss some recent results on the molecular mechanism by which autophagy plays such a role in the context of the anti-tumor immune response. We will also describe how autophagy activation can behave as a double-edged sword, by activating the immune response in some circumstances, and impairing the anti-tumor immunity in others. These findings imply that defining the precise context-specific role for autophagy in cancer is critical to guide autophagy-based therapeutics which are becoming key strategies to overcome tumor resistance to therapies.
AB - Several environmental-associated stress conditions, including hypoxia, starvation, oxidative stress, fast growth and cell death suppression, modulate both cellular metabolism and autophagy to enable cancer cells to rapidly adapt to environmental stressors, maintain proliferation and evade therapies. It is now widely accepted that autophagy is essential to support cancer cell growth and metabolism and that metabolic reprogramming in cancer can also favor autophagy induction. Therefore, this complex interplay between autophagy and tumor cell metabolism will provide unique opportunities to identify new therapeutic targets. As the regulation of the autophagic activity is related to metabolism, it is important to elucidate the exact molecular mechanism which drives it and the functional consequence of its activation in the context of cancer therapy. In this review, we will summarize the role of autophagy in shaping the cellular response to an abnormal tumor microenvironment and discuss some recent results on the molecular mechanism by which autophagy plays such a role in the context of the anti-tumor immune response. We will also describe how autophagy activation can behave as a double-edged sword, by activating the immune response in some circumstances, and impairing the anti-tumor immunity in others. These findings imply that defining the precise context-specific role for autophagy in cancer is critical to guide autophagy-based therapeutics which are becoming key strategies to overcome tumor resistance to therapies.
KW - Autophagy
KW - Hypoxia
KW - Immune response
KW - Metabolism
KW - Tumor resistance
UR - http://www.scopus.com/inward/record.url?scp=84908218156&partnerID=8YFLogxK
UR - https://www.ncbi.nlm.nih.gov/pubmed/25044308
U2 - 10.1016/j.bcp.2014.07.006
DO - 10.1016/j.bcp.2014.07.006
M3 - Review article
C2 - 25044308
AN - SCOPUS:84908218156
SN - 0006-2952
VL - 92
SP - 31
EP - 42
JO - Biochemical Pharmacology
JF - Biochemical Pharmacology
IS - 1
ER -